Manufacturing Agreement May 6, 2016Manufacturing Agreement • July 28th, 2016 • Vanda Pharmaceuticals Inc. • Pharmaceutical preparations
WHEREAS, Client previously held the rights to the Product in the whole world other than the United States of America (“USA”) and Canada; and
AGREEMENT OF SUBLEASEAgreement of Sublease • July 28th, 2016 • Vanda Pharmaceuticals Inc. • Pharmaceutical preparations
THIS AGREEMENT OF SUBLEASE (this “Sublease”), made as of June 22, 2016, between HUNTON & WILLIAMS LLP, a Virginia registered limited liability partnership (“Sublessor”), having an office at 2200 Pennsylvania Avenue, N.W., Washington, DC 20037, and VANDA PHARMACEUTICALS INC., a Delaware corporation (“Sublessee”), having an office at 2200 Pennsylvania Avenue, N.W., Washington, DC 20037, recites and provides:
AMENDMENT NO. 2 TO LEASELease • July 28th, 2016 • Vanda Pharmaceuticals Inc. • Pharmaceutical preparations
THIS AMENDMENT NO. 2 TO LEASE (“Amendment”) is made as of the 20th day of June 2016 (“Effective Date”), by and between SQUARE 54 OFFICE OWNER LLC, a Delaware limited liability company (“Landlord”), and VANDA PHARMACEUTICALS INC., a Delaware corporation (“Tenant”).
